Related references
Note: Only part of the references are listed.Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice
Sofia E. Magnusson et al.
VACCINE (2014)
Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses
Yun Young Go et al.
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH (2014)
Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010
L. R. Petersen et al.
EPIDEMIOLOGY AND INFECTION (2013)
West Nile virus and kidney disease
Luisa Barzon et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
West Nile Virus: Review of the Literature
Lyle R. Petersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
Kim Blom et al.
JOURNAL OF IMMUNOLOGY (2013)
Excretion of West Nile Virus in Urine During Acute Infection
Luisa Barzon et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice
Amelia K. Pinto et al.
JOURNAL OF VIROLOGY (2013)
Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins
Eddie A. James et al.
JOURNAL OF VIROLOGY (2013)
Vaccination of Captive Nene (Brenta sandvicensis) against West Nile Virus Using a Protein-based Vaccine (WN-80E)
Susan I. Jarvi et al.
JOURNAL OF WILDLIFE DISEASES (2013)
West Nile virus infection and immunity
Mehul S. Suthar et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals
Yvonne E. Thomassen et al.
PLOS ONE (2013)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Anna P. Durbin et al.
VACCINE (2013)
Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice
Marietjie Venter et al.
VACCINE (2013)
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
Adwoa D. Bentsi-Enchill et al.
VACCINE (2013)
A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
Anthony J. S. Chua et al.
VIROLOGY JOURNAL (2013)
CD8 and CD4 T Cells in West Nile Virus Immunity and Pathogenesis
Jason Netland et al.
VIRUSES-BASEL (2013)
Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus
Gustavo H. Dayan et al.
VIRUSES-BASEL (2013)
West Nile Virus in the United States - A Historical Perspective
John T. Roehrig
VIRUSES-BASEL (2013)
The Changing Epidemiology of Kunjin Virus in Australia
Natalie A. Prow
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2013)
A Hamster-Derived West Nile Virus Isolate Induces Persistent Renal Infection in Mice
Vandana Saxena et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
West Nile Virus, Texas, USA, 2012
Kristy O. Murray et al.
EMERGING INFECTIOUS DISEASES (2013)
A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model
Brett A. Thibodeaux et al.
ANTIVIRAL RESEARCH (2012)
Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA
I. B. Weber et al.
EPIDEMIOLOGY AND INFECTION (2012)
The future of human DNA vaccines
Lei Li et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Measles Vaccine Expressing the Secreted Form of West Nile Virus Envelope Glycoprotein Induces Protective Immunity in Squirrel Monkeys, a New Model of West Nile Virus Infection
Samantha Brandler et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Development of a new hydrogen peroxide-based vaccine platform
Ian J. Amanna et al.
NATURE MEDICINE (2012)
Prevalence of Chronic Kidney Disease and Progression of Disease Over Time among Patients Enrolled in the Houston West Nile Virus Cohort
Melissa S. Nolan et al.
PLOS ONE (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
PUBLIC HEALTH Outbreak Pattern Stymies Vaccine Work
Jocelyn Kaiser
SCIENCE (2012)
Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age
Gustavo H. Dayan et al.
VACCINE (2012)
Delayed Mortality in a Cohort of Persons Hospitalized with West Nile Virus Disease in Colorado in 2003
Nicole P. Lindsey et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2012)
Licensure of vaccines using the Animal Rule
Drusilla L. Burns
CURRENT OPINION IN VIROLOGY (2012)
Neuroinvasive Disease and West Nile Virus Infection, North Dakota, USA, 1999-2008
Paul J. Carson et al.
EMERGING INFECTIOUS DISEASES (2012)
West Nile Virus Lineage 2 from Blood Donor, Greece
Anna Papa et al.
EMERGING INFECTIOUS DISEASES (2012)
Electroporation delivery of DNA vaccines: prospects for success
Niranjan Y. Sardesai et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Critical issues in dengue vaccine development
Stephen J. Thomas et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
West Nile Virus RNA Not Detected in Urine of 40 People Tested 6 Years After Acute West Nile Virus Disease
Katherine B. Gibney et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults
Rex Biedenbender et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans
Klaus K. Orlinger et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Microarray Hybridization for Assessment of the Genetic Stability of Chimeric West Nile/Dengue 4 Virus
Majid Laassri et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Phylogeography of West Nile Virus: from the Cradle of Evolution in Africa to Eurasia, Australia, and the Americas
Fiona J. May et al.
JOURNAL OF VIROLOGY (2011)
Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms
Matthew R. Vogt et al.
JOURNAL OF VIROLOGY (2011)
Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain
J. M. Minke et al.
VACCINE (2011)
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
Rebecca J. Cox et al.
VACCINE (2011)
Evaluation of RepliVAX WN, a Single-Cycle Flavivirus Vaccine, in a Non-Human Primate Model of West Nile Virus Infection
Douglas G. Widman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge
Orly Gershoni-Yahalom et al.
IMMUNOLOGY (2010)
TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis
Stacey L. Demento et al.
JOURNAL OF IMMUNOLOGY (2010)
West Nile Fever Characteristics among Viremic Persons Identified through Blood Donor Screening
Shimian Zou et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Persistent Infection with West Nile Virus Years after Initial Infection
Kristy Murray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B. Halstead et al.
LANCET INFECTIOUS DISEASES (2010)
An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system
Klaus K. Orlinger et al.
VACCINE (2010)
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus
Melissa C. Whiteman et al.
VACCINE (2010)
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
Bruno Guy et al.
VACCINE (2010)
被撤回的出版物: A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice (Retracted article. See vol. 232, pg. 266, 2016)
Gunther Spohn et al.
VIROLOGY JOURNAL (2010)
Economic Cost Analysis of West Nile Virus Outbreak, Sacramento County, California, USA, 2005
Loren M. Barber et al.
EMERGING INFECTIOUS DISEASES (2010)
Wanted, dead or alive: New viral vaccines
Ian J. Amanna et al.
ANTIVIRAL RESEARCH (2009)
Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys
Michael M. Lieberman et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
The host immunologic response to West Nile encephalitis virus
Michael S. Diamond et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step
Matthew R. Vogt et al.
JOURNAL OF VIROLOGY (2009)
Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01
Arun V. Iyer et al.
VACCINE (2009)
Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII
Mathura P. Ramanathan et al.
VACCINE (2009)
The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses
J. S. Mackenzie et al.
ZOONOSES AND PUBLIC HEALTH (2009)
A global perspective on the epidemiology of West Nile virus
Laura D. Kramer et al.
ANNUAL REVIEW OF ENTOMOLOGY (2008)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
The structural immunology of antibody protection against West Nile virus
Michael S. Diamond et al.
IMMUNOLOGICAL REVIEWS (2008)
Effects of West Nile virus may persist
Rebecca Voelker
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus
David C. Chang et al.
NATURE BIOTECHNOLOGY (2008)
Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
Frederic Coutant et al.
PLOS ONE (2008)
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system
Douglas G. Widman et al.
VACCINE (2008)
Attenuated West Nile viruses bearing 3′SL and envelope gene substitution mutations
Li Yu et al.
VACCINE (2008)
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus
Bimmi Shrestha et al.
VACCINE (2008)
Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine
Chang-Kweng Lim et al.
VIROLOGY (2008)
Maturation of west nile virus modulates sensitivity to antibody-mediated neutralization
Steevenson Nelson et al.
PLOS PATHOGENS (2008)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
Julie E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine
Itzchak Samina et al.
VACCINE (2007)
Induction of epitope-specific neutralizing antibodies against west nile virus
Theodore Oliphant et al.
JOURNAL OF VIROLOGY (2007)
Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model
M. T. Long et al.
EQUINE VETERINARY JOURNAL (2007)
The continuing spread of West Nile virus in the Western Hemisphere
Duane J. Gubler
CLINICAL INFECTIOUS DISEASES (2007)
Complex adenovirus-mediated expression of West Nile Virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses
Jennifer Schepp-Berglind et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice
Tomohiro Ishikawa et al.
MICROBES AND INFECTION (2007)
Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection
James D. Brien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
The long-term outcomes of human West Nile virus infection
James J. Sejvar
CLINICAL INFECTIOUS DISEASES (2007)
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity
William F. McDonald et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis
Douglas M. Watts et al.
VACCINE (2007)
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection
Jang-Hann J. Chu et al.
JOURNAL OF IMMUNOLOGY (2007)
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine
Michael M. Lieberman et al.
VACCINE (2007)
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system
Elizabeth M. Sitati et al.
JOURNAL OF VIROLOGY (2006)
Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives
Alexey Seregin et al.
VIROLOGY (2006)
Chimeric West Nile/dengue virus vaccine candidate: Preclinical evaluation in mice, geese and monkeys for safety and immunogenicity
Alexander G. Pletnev et al.
VACCINE (2006)
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus
M Throsby et al.
JOURNAL OF VIROLOGY (2006)
A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice
Jason A. Wicker et al.
VIROLOGY (2006)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cost-effectiveness of West Nile virus vaccination
A Zohrabian et al.
EMERGING INFECTIOUS DISEASES (2006)
A single amino acid substitution in the west nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice
WJ Liu et al.
JOURNAL OF VIROLOGY (2006)
A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus
Maria Candela Iglesias et al.
JOURNAL OF GENE MEDICINE (2006)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
Long-term death rates, West Nile virus epidemic, Israel, 2000
MS Green et al.
EMERGING INFECTIOUS DISEASES (2005)
Virology, pathology, and clinical manifestations of West Nile virus disease
EB Hayes et al.
EMERGING INFECTIOUS DISEASES (2005)
Persistent West Nile virus infection in the golden hamster: Studies on its mechanism and possible implications for other flavivirus infections
RB Tesh et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
West Nile virus-associated flaccid paralysis
JJ Sejvar et al.
EMERGING INFECTIOUS DISEASES (2005)
A recombinant envelope protein vaccine against West Nile virus
M Ledizet et al.
VACCINE (2005)
Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge
K Karaca et al.
VACCINE (2005)
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
T Oliphant et al.
NATURE MEDICINE (2005)
West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response
A Anwar et al.
VIROLOGY (2005)
Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis
P Desprès et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Clinical characteristics and functional outcomes of West Nile fever
JT Watson et al.
ANNALS OF INTERNAL MEDICINE (2004)
Induction of sterilizing immunity against west nile virus (WNV), by immunization with WNV-like particles produced in insect cells
M Qiao et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development
G Yamshchikov et al.
VIROLOGY (2004)
Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses
L Siger et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy
J Arroyo et al.
JOURNAL OF VIROLOGY (2004)
West Nile virus economic impact, Louisiana, 2002
A Zohrabian et al.
EMERGING INFECTIOUS DISEASES (2004)
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice
MJ Engle et al.
JOURNAL OF VIROLOGY (2003)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus
AG Pletnev et al.
VIROLOGY (2003)
DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus
RA Hall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neurologic manifestations and outcome of West Nile virus infection
JJ Sejvar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
West Nile virus infection - A new acute paralytic illness
LE Jeha et al.
NEUROLOGY (2003)
Acute flaccid paralysis and West Nile virus infection
JJ Sejvar et al.
EMERGING INFECTIOUS DISEASES (2003)
Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice
D Ben-Nathan et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Asymmetric flaccid paralysis: A neuromuscular presentation of West Nile virus infection
J Li et al.
ANNALS OF NEUROLOGY (2003)
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model
RB Tesh et al.
EMERGING INFECTIOUS DISEASES (2002)
First isolation of West Nile virus from a patient with encephalitis in the United States
CN Huang et al.
EMERGING INFECTIOUS DISEASES (2002)
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates
F Guirakhoo et al.
VIROLOGY (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Immunization of mice against West Nile virus with recombinant envelope protein
T Wang et al.
JOURNAL OF IMMUNOLOGY (2001)
Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey
F Mostashari et al.
LANCET (2001)
West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays
BS Davis et al.
JOURNAL OF VIROLOGY (2001)
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
TP Monath et al.
JOURNAL OF VIROLOGY (2000)
A live attenuated West Nile virus strain as a potential veterinary vaccine
S Lustig et al.
VIRAL IMMUNOLOGY (2000)
Share Paper
